US Edition
Centinel Spine Posts Record Revenue as prodisc Sales Rise 47% in Q2
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Centinel Spine Posts Record Revenue as prodisc Sales Rise 47% in Q2
WEST CHESTER, PA — Centinel Spine has recorded its strongest quarterly performance to date, reporting $32.6 million in worldwide prodisc revenue for the second quarter of 2025. That marks a 47% increase compared to the same period last year. The prodisc product line, deployed for both cervical and lumbar spine treatments, achieved record-breaking figures across the board. Cervical prodisc revenue reached $19.2 million—up 32% year-over-year—while…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
